Loading...
Loading...
A| Name | Value |
|---|---|
| Revenues | 1,681.0M |
| Cost of Revenue | 782.0M |
| Gross Profit | 899.0M |
| Operating Expense | 523.0M |
| Operating I/L | 376.0M |
| Other Income/Expense | -9.0M |
| Interest Income | 15.0M |
| Pretax | 367.0M |
| Income Tax Expense | 49.0M |
| Net Income/Loss | 318.0M |
Agilent Technologies, Inc. provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets globally. The company's Life Sciences and Applied Markets segment offers a wide range of instruments and technologies for chromatography, mass spectrometry, spectroscopy, cell analysis, and laboratory automation. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, next-generation sequencing, and genetic data management. Additionally, Agilent CrossLab offers laboratory supplies, services, and support. The company generates revenue through direct sales, distributors, resellers, and electronic commerce.
